Hutchison China MediTech Limited ("Chi-Med")
(AIM: HCM)
Notice of Announcement of 2011 Interim Results
London: Tuesday, 5 July 2011: Chi-Med will be announcing its interim results for the six months ended 30 June 2011 on Monday, 1 August 2011.
Ends
Enquiries
Chi-Med Christian Hogg, CEO |
Telephone: +852 2121 8200 |
|
|
Citigate Dewe Rogerson Anthony Carlisle David Dible |
Telephone: +44 (0) 20 7638 9571 Mobile: +44 (0) 7973 611 888 Mobile: +44 (0) 7967 566 919
|
Lazard & Co., Limited Paul Gismondi Nick Fowler |
Telephone: +44 (0) 20 7187 2000
|
About Chi-Med
Chi-Med is the holding company of a healthcare group based primarily in China and was listed on the Alternative Investment Market of the London Stock Exchange in May 2006. It is focused on researching, developing, manufacturing and selling pharmaceuticals and health oriented consumer products.
Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.